Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026)

Zai Lab (ZLAB) posted quarterly Other Accumulated Expenses of $47.0 million for Q1 2026, up 27.71% year-on-year from $36.8 million in Q1 2025, and down 26.18% on a QoQ basis from $63.7 million in Q4 2025.

Zai Lab (ZLAB) Other Accumulated Expenses (2016 - 2026) Analysis & Trends

Zai Lab (ZLAB) has reported Other Accumulated Expenses for 11 consecutive years, with $47.0 million the latest figure, recorded in Q1 2026.

  • Quarterly Other Accumulated Expenses rose 27.71% year-over-year to $47.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $47.0 million (up 27.71% YoY) and the FY2025 annual result came in at $63.7 million, up 8.45% from the prior year.
  • Other Accumulated Expenses slipped to $47.0 million in Q1 2026 per ZLAB's latest filing, from $63.7 million in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for ZLAB reached as high as $83.0 million in Q4 2023 and fell as low as $36.8 million in Q1 2025.
  • A 5-year average of $54.5 million and a median of $51.5 million in 2025 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses fell 29.23% — and 2026, when it climbed 27.71%.
  • Year by year, Other Accumulated Expenses stood at $66.8 million in 2022, then climbed by 24.18% to $83.0 million in 2023, then decreased by 29.23% to $58.7 million in 2024, then grew by 8.45% to $63.7 million in 2025, then retreated by 26.18% to $47.0 million in 2026.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $47.0 million, $63.7 million, and $51.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Zai Lab 20.66 Bn 19.91 Bn 61.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 47.01 Mn
Dec 31, 2025 63.68 Mn
Sep 30, 2025 51.54 Mn
Jun 30, 2025 44.05 Mn
Mar 31, 2025 36.81 Mn
Dec 31, 2024 58.72 Mn
Sep 30, 2024 46.08 Mn
Jun 30, 2024 46.50 Mn
Mar 31, 2024 48.18 Mn
Dec 31, 2023 82.97 Mn
Sep 30, 2023 62.99 Mn
Jun 30, 2023 59.02 Mn
Mar 31, 2023 50.88 Mn
Dec 31, 2022 66.82 Mn
Sep 30, 2022 58.46 Mn
Jun 30, 2022 53.61 Mn
Mar 31, 2022 49.96 Mn
Dec 31, 2021 60.81 Mn
Sep 30, 2021 54.29 Mn
Jun 30, 2021 61.93 Mn